Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets

Arthritis and Rheumatism

Volumn 60, Issue 11, 2009, Pages 3485-3492

  Hollis Moffatt, Jade E ^a   Xu, Xin ^a   Dalbeth, Nicola ^b   Merriman, Marilyn E ^a   Topless, Ruth ^a   Waddell, Chloe ^b   Gow, Peter J ^c   Harrison, Andrew A ^a   Highton, John ^a   Jones, Peter B B ^b   Stamp, Lisa K ^d   Merriman, Tony R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c MIDDLEMORE HOSPITAL   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; PROTEIN SLC2A9; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GOUT; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PACIFIC ISLANDS; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GOUT; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; ORGANIC ANION TRANSPORTERS; PACIFIC ISLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 70350523960     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24938     Document Type: Article

References (22)

1. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-26
2. Dalbeth N, Gow P. Prevention of colchicine toxicity in patients with gout. N Z Med J 2007;120:U2503.
3. Dalbeth N, Kumar S, Stamp L, Gow PJ. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricaemia in patients with gout. J Rheumatol 2006;33:1646-1650 (Pubitemid 44168841)
4. Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007;46:1804-1807 (Pubitemid 350168295)
5. Gibson T, Highton J, Potter C, Simmonds HA. Renal impairment and gout. Ann Rheum Dis 1980;39:417-423
6. Gibson T, Waterworth R, Hatfield P, Robinson G, Bremner K. Hyperuricaemia, gout and kidney function in New Zealand Māori men. Br J Rheumatol 1984;23:276-282 (Pubitemid 14015865)
7. Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994;33:932-937 (Pubitemid 24324808)
8. Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006;54:292-300. (Pubitemid 43124109)
9. Shima Y, Teruya, Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006;79:2234-2237
10. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WH, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide study. Lancet 2008;372:1953-1961
11. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007;3:e194. (Pubitemid 350291576)
12. Brandstatter A, Kiechl S, Kollerits B, Hunt SC, Heid IM, Coassin S, et al. The gender-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 2008;31:1662-1667
13. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008;40:430-436
14. McArdle PF, Parsa A, Chang YP, Weir MR, O'Connell JR, Mitchell BD, et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in Old Order Amish. Arthritis Rheum 2008;58:2874-2881
15. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008;40:437-442
16. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008;82:139-149 (Pubitemid 351735954)
17. Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A, et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS ONE 2008;3:e1948. (Pubitemid 351984398)
18. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, Doblado M, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008;5:e197.
19. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
20. Renfrew C. Anthropology: where bacteria and languages concur. Science 2009;323:467-468
21. Harrold LR, Saag KG, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, et al. Validity of gout diagnoses in administrative data. Arthritis Rheum 2007;57:103-108 (Pubitemid 46256731)
22. Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 2007;66:1311-1315 (Pubitemid 47492473)